Sort
11,323 grants matching “glioblastoma”
Mitigation of cognitive impairments from radiation therapy
$0Ting-Ting Huang · Veterans Admin Palo Alto Health Care Sys · I01 · FY2022 · VA
Development of Recombinant Toxins for Treatment of Patients with Hematologic Mal
$0Basic Sciences · Z01 · FY2000 · BC
RSR13 ADMINISTERED TO PATIENTS RECEIVING CRANIAL RADIATION THERAPY
$0University Of Pennsylvania · M01 · FY2000 · RR
A PHASE I STUDY OF HYDROXYUREA &PENTOXYFYLLINE FOR TREA
$0Clinical Sciences · Z01 · FY2000 · SC
LARGE SCALE GENE EXPRESSION ANALYSIS TO IDENTIFY MALIGNANT GLIOMAS
$0Duke University · P20 · FY2002 · CA
METABOLIC GENES AND THE RISK AND OUTCOME OF PRIMARY BRAIN TUMORS
$0Duke University · P20 · FY2002 · CA
Molecular Pathogenesis Of Jc Virus &Progressive Multifo
$0Neurological Disorders And Stroke · Z01 · FY2004 · NS
Signal transduction blockade and high-grade gliioma
$0Sloan-Kettering Institute For Cancer Res · P20 · FY2002 · CA
Nanoplatform Delivery of MDA-7 and Brachytherapy for Treatment of Brain Tumors
$0Michael D Shultz · Va Veterans Administration Hospital · IK2 · FY2014 · VA
Mechanisms of Resistance to mTOR Targeted Therapies
$0Joseph F Gera · Va Greater Los Angeles Healthcare System · I01 · FY2020 · VA
Modeling IDH Mutant Gliomas by Genetic Engineering of Brain Organoid
$0Xiaosi Han · Birmingham Va Medical Center · I01 · FY2025 · VA
Molecular Pathogenesis Of Jc Virus &Progressive Multifo
$0Neurological Disorders And Stroke · Z01 · FY2003 · NS
Mechanisms of Resistance to mTOR Targeted Therapies
$0Joseph F Gera · Va Greater Los Angeles Healthcare System · I01 · FY2019 · VA
Delivery issues in lung cancer CNS metastases
$0Edward A Neuwelt · Portland Va Medical Center · I01 · FY2015 · VA
Interferon-mediated suppression of MMP-9 gene expression and function in gliomas
$0University Of Alabama At Birmingham · P50 · FY2002 · CA
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE
$0University Of North Carolina Chapel Hill · M01 · FY2000 · RR
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE
$0University Of North Carolina Chapel Hill · M01 · FY2000 · RR
Interactions between inflammatory and oncogenic signaling pathways in GBM
$0Amyn Habib · Va North Texas Health Care System · I01 · FY2016 · VA
Mechanisms of Resistance to mTOR-Targeted Therapies
$0Joseph F Gera · Va Greater Los Angeles Healthcare System · I01 · FY2015 · VA
SU101 FOR PTS W/ ANAPLASTIC ASTROCYTOMA IN FIRST RELAPSE
$0University Of North Carolina Chapel Hill · M01 · FY2000 · RR
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME PTS
$0University Of North Carolina Chapel Hill · M01 · FY2000 · RR
Targeting the Hedgehog pathway in glioma tumor-initiating cells
$0Michael K Cooper · Veterans Health Administration · I01 · FY2012 · VA
Single Cell Analysis of Genetic Heterogeneity in Pathogenic Cell Populations
$0Louis Joseph Dell'italia · Birmingham Va Medical Center · IS1 · FY2015 · VA
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME PTS
$0University Of North Carolina Chapel Hill · M01 · FY2000 · RR
SU101 VS PROCARBAZINE FOR GLIOBLASTOMA MULTIFORME PTS
$0University Of North Carolina Chapel Hill · M01 · FY2000 · RR